Literature DB >> 21774932

Self-reported adverse drug events and the role of illness perception and medication beliefs in ambulatory heart failure patients: A cross-sectional survey.

Ruth H E De Smedt1, Petra Denig, Klaas van der Meer, Flora M Haaijer-Ruskamp, Tiny Jaarsma.   

Abstract

BACKGROUND: Identifying patients with heart failure (HF) who are at risk of experiencing symptomatic adverse drug events (ADEs) is important for improving patient care and quality of life. Several demographic and clinical variables have been identified as potential risk factors for ADEs but limited knowledge is available on the impact of HF patients' beliefs and perceptions on their experience of ADEs.
OBJECTIVE: The purpose of the study was to identify the relationship between HF patients' illness perception and medication beliefs and self-reported ADEs.
DESIGN: A cross-sectional survey was performed between November 2008 and March 2009. SETTINGS: One university medical centre, two regional hospitals and 20 general practitioners in the Netherlands participated in the study. PARTICIPANTS: 495 patients with HF were included.
METHODS: Patients completed the validated Revised Illness Perception Questionnaire (IPQ-R) and the Beliefs about Medication Questionnaire (BMQ) which collected data on their illness perception and medication beliefs. In addition, data on ADEs as experienced in the previous four weeks were collected through an open-ended question and a symptom checklist. Multivariate logistic regression was performed to identify factors associated with these ADEs.
RESULTS: In total, 332 (67%) patients had experienced ADEs in the previous four weeks, of whom 28% reported dry mouth, 27% dizziness and 19% itchiness as the most prevalent. In the adjusted multivariate analysis, disease-related symptoms (illness identity) (OR for 1-5 symptoms 3.57; 95% CI 2.22-5.75, OR for >5 symptoms 7.37; 95% CI 3.44-15.8), and general beliefs about medication overuse (OR 1.07; 95% CI 1.01-1.13) were independently associated with experiencing ADEs, whereas none of the demographic or clinical factors were significant.
CONCLUSIONS: HF patients who perceive a high number of disease symptoms and have negative medication beliefs are at higher risk of experiencing self-reported ADEs. We suggest that future studies and interventions to improve ADE management should focus on negative medication beliefs and assisting patients in differentiating disease symptoms from ADEs. 2011. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21774932     DOI: 10.1016/j.ijnurstu.2011.05.014

Source DB:  PubMed          Journal:  Int J Nurs Stud        ISSN: 0020-7489            Impact factor:   5.837


  6 in total

Review 1.  Categorization and association analysis of risk factors for adverse drug events.

Authors:  Lina Zhou; Anamika Paul Rupa
Journal:  Eur J Clin Pharmacol       Date:  2017-12-08       Impact factor: 2.953

2.  Use of information sources regarding medicine side effects among the general population: a cross-sectional survey.

Authors:  Bernadine O'Donovan; Ruth M Rodgers; Anthony R Cox; Janet Krska
Journal:  Prim Health Care Res Dev       Date:  2019-12-10       Impact factor: 1.458

3.  Self-care of heart failure patients: practical management recommendations from the Heart Failure Association of the European Society of Cardiology.

Authors:  Tiny Jaarsma; Loreena Hill; Antoni Bayes-Genis; Hans-Peter Brunner La Rocca; Teresa Castiello; Jelena Čelutkienė; Elena Marques-Sule; Carla M Plymen; Susan E Piper; Barbara Riegel; Frans H Rutten; Tuvia Ben Gal; Johann Bauersachs; Andrew J S Coats; Ovidiu Chioncel; Yuri Lopatin; Lars H Lund; Mitja Lainscak; Brenda Moura; Wilfried Mullens; Massimo F Piepoli; Giuseppe Rosano; Petar Seferovic; Anna Strömberg
Journal:  Eur J Heart Fail       Date:  2020-10-20       Impact factor: 15.534

Review 4.  Atrial fibrillation and thromboprophylaxis in heart failure: the need for patient-centered approaches to address adherence.

Authors:  Caleb Ferguson; Sally C Inglis; Phillip J Newton; Sandy Middleton; Peter S Macdonald; Patricia M Davidson
Journal:  Vasc Health Risk Manag       Date:  2013-01-16

Review 5.  Eliciting adverse effects data from participants in clinical trials.

Authors:  Elizabeth N Allen; Clare Ir Chandler; Nyaradzo Mandimika; Cordelia Leisegang; Karen Barnes
Journal:  Cochrane Database Syst Rev       Date:  2018-01-16

6.  Drug therapy problems and contributing factors in the management of heart failure patients in Jimma University Specialized Hospital, Southwest Ethiopia.

Authors:  Yirga Legesse Niriayo; Kabaye Kumela; Tesfaye Dessale Kassa; Mulugeta Tarekegn Angamo
Journal:  PLoS One       Date:  2018-10-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.